Table 1.
Baseline clinical data of Cushing’s disease patients treated with ketoconazole.
| Variable | Total, n = 38 (%) |
|---|---|
| Sex (F/M) | 32/6 (84.2/15.8%) |
| Age (years) | 31.7 (11–51) |
| Ethnicity (White/non-White) | 34/4 (89.5/10.5%) |
| Facial plethora | 22 (57.9%) |
| Diabetes mellitus | 12 (36%) |
| Hypertension | 26 (78%) |
| Purpuric striae | 21 (55.3%) |
| Acne | 11 (28.9%) |
| Proximal weakness | 19 (50%) |
| Supraclavicular fat | 17 (44.7%) |
| “Buffalo hump” | 22 (57.9%) |
| Psychiatric illness | 12 (31.6%) |
| Microadenoma Macroadenoma Normal MRI Unavailable |
11 (28.94%) 15 (39.47%) 11 (28.94%) 1 (2.63%) |